[Asia Economy Reporter Kim Heung-soon] Nexton announced on the 15th that it plans to change its trade name to 'Nexton Bioscience' ahead of the regular shareholders' meeting scheduled for the 30th. The company will also add pharmaceutical development to the business objectives in its articles of incorporation to enter the bio business, including new drug development. Accordingly, former Sillajen Vice President Song Myung-seok is expected to be appointed as the head of the new bio business division.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
